SCHEMBL24535674

SCHEMBL24535674

CCc1c(F)ccc2cc(O)cc(-c3ncc4c(OCC(F)(F)F)nc(OC)nc4c3F)c12

nearest known ligand 0.48

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KRAS P01116 20/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29680489 0.85 KRAS (0.52) KRAS
SCHEMBL24536826 0.85 KRAS (0.52) KRAS
SCHEMBL29680343 0.84 KRAS (0.70) KRAS
SCHEMBL24536723 0.84 KRAS (0.70) KRAS
SCHEMBL24535809 0.84 KRAS (0.51) KRAS
SCHEMBL24536562 0.83 KRAS (0.50) KRAS
SCHEMBL29679897 0.83 KRAS (0.55) KRAS
SCHEMBL24537647 0.83 KRAS (0.49) KRAS
SCHEMBL25165679 0.81 KRAS (0.63) KRAS
SCHEMBL24535814 0.81 KRAS (0.62) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022132200-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2022-06-23 — — WO disclosed
Send feedback